http://ift.tt/2rML9iu Sun Pharma’s profitability took a hard knock in the fourth quarter, but what’s worse is the management guidance of a single-digit sales decline in FY18
May 29, 2017 at 07:41AM
http://ift.tt/2qtfhvh
from Ravi Ananthanarayanan
No comments:
Post a Comment